Prevention of Alzheimer's disease by treating mild cognitive impairment with combinations chosen from eight available drugs
Abstract Several hundred clinical trials of initially promising drugs have failed to produce meaningful clinical improvement of Alzheimer's disease (AD), which is probably because there are at least 25 biochemical pathways known to be aberrant that underpin the disease, and unless there is a si...
Saved in:
| Main Author: | Jeffrey Fessel |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2019-01-01
|
| Series: | Alzheimer’s & Dementia: Translational Research & Clinical Interventions |
| Online Access: | https://doi.org/10.1016/j.trci.2019.09.019 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Choroidal Thickness in Patients with Mild Cognitive Impairment and Alzheimer’s Type Dementia
by: Mehmet Bulut, et al.
Published: (2016-01-01) -
Advanced AI techniques for classifying Alzheimer’s disease and mild cognitive impairment
by: Sophie Tascedda, et al.
Published: (2024-11-01) -
Intervention Effects of the Holistic Physio-Cognitive Rehabilitation for Alzheimer Disease and Mild Cognitive Impairment
by: Aiko Osawa, et al.
Published: (2025-06-01) -
Development and validation of a combined clinical and MRI‐based biomarker model to differentiate mild cognitive impairment from mild Alzheimer's disease
by: Zohreh Hosseini, et al.
Published: (2025-06-01) -
The Greek Version of the Mild Behavioral Impairment Checklist (MBI-C): Psychometric Properties in Mild Cognitive Impairment Due to Alzheimer’s Disease
by: Efthalia Angelopoulou, et al.
Published: (2025-04-01)